A phase 1 study of selinexor (S) in combination with paclitaxel (P) and carboplatin (C) in patients (pts) with advanced ovarian (OC) or endometrial cancers (EC)
Year: 2017
Type: article
Study design: Clinical Trial
Source: Annals of Oncology
Authors: V. Makker, N. Boucicaut, K.A. Cadoo, R. Grisham, D.M. Hyman, R. O'Cearbhail, A. Snyder Charen, W. Tew, M. Martin, C. Aghajanian
Institution: Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2761789400
